Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFA9P1 is a human pseudogene, officially named NADH:ubiquinone oxidoreductase subunit A9 pseudogene 1. It is annotated and referenced in multiple genetics databases as a pseudogene and does not encode a protein. It is unrelated to the function of its parent gene NDUFA9, which is a mitochondrial electron transport chain subunit implicated in various mitochondrial diseases. As a pseudogene, NDUFA9P1 is not considered a therapeutic target, does not play a known biological role, and has no known associations with disease, drugs, or clinical biomarkers[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A9 pseudogene 1 (NDUFA9P1).